TABERNACLE HEALTH GROUP LAUNCHES CHINESE PROPRIETARY MEDICINE, AVROCIL (TM) COLD AND FLU AID
SINGAPORE, Feb. 10, 2022 /PRNewswire/ -- As we enter the cold and flu season, it can be cumbersome to fall sick when the rest of the world is celebrating the New Year. Avrocil™ – Cold & Flu Aid (Product Photos) For those who have come down with cold and flu this season, exploring Chinese Proprietary Medicines...
Well Begun AND Half Done! – SIRONA Randomized Trial Achieves fifty percent enrollment
JENA, Germany, Feb. 10, 2022 /PRNewswire/ -- Concept Medical Inc., focused on vascular intervention drug delivery devices, releases the second status update of SIRONA RCT (Head-to-Head Comparison of SIROlimus versus Paclitaxel Drug-Eluting BallooN Angioplasty in the Femoropopliteal Artery), as the trial completes half the targeted enrolment. Concept_Medical_NASDAQ SIRONA is the...
NSF International’s President and Chief Executive Officer (CEO) Kevan Lawlor Announces Retirement; Pedro Sancha to Succeed Lawlor as President and CEO
ANN ARBOR, Mich., Feb. 9, 2022 /PRNewswire/ -- NSF International (NSF) announced today that President and Chief Executive Officer (CEO) Kevan P. Lawlor has decided to retire in 2022 and Pedro Sancha will become the organization's next President and CEO. Kevan Lawlor Pedro Sancha "On behalf of the Board of Directors, the leadership...
Correction: Year-end report 2021 Bactiguard Holding AB
STOCKHOLM, Feb. 9, 2022 /PRNewswire/ -- In previous press releases regarding the year-end report for 2021, incorrect information related to "Cash flow from operating activities" has been reported. Correction is made with this press release and the correct PDF is attached for Bactiguard Holding AB's (publ) year-end report 2021. Investments for future sales growth impacted profitability Fourth quarter (October-December...
X-Chem and Excelra’s GOSTAR Join Forces to Advance Drug Discovery for Challenging Targets
LONDON and HYDERABAD, India, Feb. 9, 2022 /PRNewswire/ -- A new collaboration between data science and analytics leader, Excelra, and artificial intelligence pioneer X-Chem will accelerate preclinical drug discovery and aid scientists to find new drug candidates for currently hard-to-drug targets. Machine learning and artificial intelligence are reshaping discovery and optimization...
Sirtex Medical and Grand Pharmaceutical Group Limited receive NDA approval of SIR-Spheres® Y-90 resin microspheres in China from the National Medical Products Administration
SIR-Spheres® Y-90 resin microspheres are the first therapeutic radiopharmaceutical approved by the NMPA in 2022 WOBURN, Mass., Feb. 9, 2022 /PRNewswire/ -- Sirtex Medical ("Sirtex"), a leading manufacturer of targeted liver cancer therapies, announced today with its shareholder, Grand Pharmaceutical Group Limited, that SIR-Spheres® Y-90 resin microspheres have been approved by the...
Angel Yeast’s Patented Probiotic S. boulardii Alleviates Common IBD Symptoms, New Research Shows
YICHANG, China, Feb. 9, 2022 /PRNewswire/ -- Angel Yeast Co., Ltd("Angel Yeast"), a listed global yeast and yeast extract manufacturer, has partnered with the Huazhong University of Science and Technology to conduct a clinical study that investigated the relationship between Saccharomyces boulardii Bld-3 (S. boulardii) and inflammatory bowel disease (IBD). The results of...
Prota Therapeutics Achieves Peanut Allergy Treatment Milestone: Groundbreaking Clinical Trial Data Demonstrates Clinical Remission of Peanut Allergy in Paediatric Patients
Groundbreaking New Clinical Trial Data Published in The Lancet Child & Adolescent Health Data shows that 51% of participants achieved sustained unresponsiveness (clinical remission) to peanut after 18 months of treatment Prota Therapeutics announces new round of capital raising for further P3 clinical investigation and global commercialization of its...
Mobile Medical Imaging Systems Improving Care Accessibility and Convenience for Patients
Portability and cost-effectiveness are key factors propelling the adoption of mobile medical imaging technology globally, says Frost & Sullivan SAN ANTONIO, Feb. 9, 2022 /PRNewswire/ -- Frost & Sullivan's recent analysis finds that the drawbacks of traditional medical imaging platforms are driving the need for novel mobile medical imaging systems. They offer portability and cost-effective solutions for health professionals to...
Best-in-class companies in Asia-Pacific Recognized by the Frost & Sullivan Best Practices
12 organizations lauded for their exemplary performance and valuable contributions in shaping new trends SINGAPORE, Feb. 9, 2022 /PRNewswire/ -- Frost & Sullivan's Best Practices Awards commend leading companies that have accomplished innovative or disruptive breakthroughs and have continually demonstrated excellence in their respective industries. Frost & Sullivan follows its proprietary, measurement-based methodology combined with extensive...
